Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

126.55 -0.82 (-0.64%)
Official Closing Price Updated: 4:10 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,327,661
Open 124.63
Bid (Size) 126.41 (600)
Ask (Size) 126.60 (100)
Prev. Close 127.37
Today's Range 124.15 - 127.31
52wk Range 66.66 - 132.09
Shares Outstanding 541,500
Dividend Yield 1.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗
The company announced that the U.S. FDA lifted a clinical hold on its Phase 3 trial of ATTR-CM treatment drug. 
Via Stocktwits
News headline image
Why Did QURE Stock Almost Halve Pre-Market Today? ↗
uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130. 
Via Stocktwits

Performance

YTD
+4.1%
+4.1%
1 Month
+1.4%
+1.4%
3 Month
+5.6%
+5.6%
6 Month
+36.3%
+36.3%
1 Year
+47.8%
+47.8%

More News

Read More
News headline image
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗
Via Stocktwits
News headline image
IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial ↗
Via Stocktwits
News headline image
CLDX Soars On Bullish Timelines For Urticaria Clinical Program: Retail Sees Experimental Skin Treatment’s Sales Beat Big Pharma’s Dupixent ↗
Via Stocktwits
Topics Earnings
News headline image
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts ↗
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Why Did PVLA Stock Surge 45% In Pre-Market Today? ↗
Via Stocktwits
News headline image
RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder ↗
Via Stocktwits
News headline image
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts ↗
Via Stocktwits
News headline image
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗
Via Stocktwits
Topics Earnings Intellectual Property
News headline image
GRAL Stock Slumps After Hours As Trial For Cancer Test Fails To Show Reduction In Late-Stage Diagnoses ↗
Via Stocktwits
Topics Artificial Intelligence Death
News headline image
ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries ↗
Via Stocktwits
News headline image
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition ↗
Via Stocktwits
News headline image
IBRX Gains 30% On Fresh Approval For Bladder Cancer Drug In EU: Retail, Wall Street Eyes Further Rally ↗
Via Stocktwits
News headline image
IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’ ↗
Via Stocktwits
News headline image
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU ↗
Via Stocktwits
News headline image
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty ↗
Via Stocktwits
News headline image
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗
Via Stocktwits
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Why Did RGNX Shares Plummet 19% After-Hours Today? ↗
Via Stocktwits
News headline image
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗
Via Stocktwits
Topics Artificial Intelligence

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 126.55
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 03/02/26 04:10 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 68.53M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 69M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.